Bank of Montreal
GALT icon

Bank of Montreal’s Galectin Therapeutics GALT Stock Holding History

Bank of Montreal’s Portfolio GALT Stock Details GALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-85,300
Closed -$244K – 4305
2019
Q4 		$244K Hold
85,300
– – ﹤0.01% 3051
2019
Q3 		$313K Buy
85,300
+77,900
+1,053% +$282K ﹤0.01% 2672
2019
Q2 		$31K Sell
7,400
-95,100
-93% -$412K ﹤0.01% 3912
2019
Q1 		$524K Sell
102,500
-209,100
-67% -$1M ﹤0.01% 2276
2018
Q4 		$1.07M Buy
311,600
+145,100
+87% +$693K ﹤0.01% 1857
2018
Q3 		$1M Buy
166,500
+79,600
+92% +$438K ﹤0.01% 1997
2018
Q2 		$553K Buy
+86,900
New +$423K ﹤0.01% 2290

Other funds holding GALT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GWM
Geneos Wealth Management Englewood, Colorado $4.9B AUM 23.65% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCB
Cutter & Co Brokerage Ballwin, Missouri $423M AUM 15.02% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of Montreal's GALT Position: Q4 2021 in Review

Bank of Montreal sold out of Galectin Therapeutics (GALT) in Q4 2021, closing a stake of 20,432 shares — an estimated $80K sold.

Bank of Montreal first reported a position in GALT in Q4 2014 and held it in 20 quarters. The position peaked at $1.07M in Q4 2018. 55 funds tracked by Wall St. Rank hold GALT as of Q4 2021.

  • Bank of Montreal reported no remaining Galectin Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Bank of Montreal sold 20,432 Galectin Therapeutics shares in Q4 2021, an estimated $80K.
  • Bank of Montreal first reported a position in Galectin Therapeutics in Q4 2014 and held it in 20 quarters.
  • Bank of Montreal's Galectin Therapeutics position peaked at $1.07M in Q4 2018.
  • 55 funds tracked by Wall St. Rank held Galectin Therapeutics as of Q4 2021.

Based on Bank of Montreal's 13F filing for Q4 2021, filed 11 Feb 2022.